United Kingdom · Question · Written question
HL HL5937
Tixagevimab/cilgavimab
Introduced
27 February 2023
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
6 March 2023
Summary
To ask His Majesty's Government why Evusheld was not referred to the National Institute for Health and Care Excellence (NICE) until 10 August 2022 despite the review process starting on 8 June 2022; and how timelines can be tightened in future decision ma
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.